Study of survivin and X-linked inhibitor of apoptosis protein (XIAP) genes in acute myeloid leukemia (AML)

Laboratory Hematology

Volumn 18, Issue 1, 2012, Pages 1-10

  Ibrahim, Azza Mostafa ^a   Mansour, Iman Maher ^a   Wilson, Manal Michel ^a   Mokhtar, Doha Abdel Hamid ^a   Helal, Amani Mohamed ^b   Al Wakeel, Hanan Mohamed ^a  

^a CAIRO UNIVERSITY   (Egypt)

^b CAIRO UNIVERSITY   (Egypt)

Author keywords

Acute myeloid leukemia (AML); Apoprosis; Survivin; X linked inhibitor of apoprosis protein (XIAP)

Indexed keywords

CYTARABINE; DOXORUBICIN; SURVIVIN; X LINKED INHIBITOR OF APOPTOSIS;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER PROGNOSIS; CANCER REGRESSION; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG RESPONSE; FEMALE; GENE EXPRESSION PROFILING; GENE OVEREXPRESSION; HUMAN; MALE; OUTCOME ASSESSMENT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL RATE; SURVIVAL TIME;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; FEMALE; GENE EXPRESSION; HUMANS; INDUCTION CHEMOTHERAPY; INHIBITOR OF APOPTOSIS PROTEINS; KAPLAN-MEIER ESTIMATE; LEUKEMIA, MYELOID, ACUTE; MALE; MIDDLE AGED; PROGNOSIS; TREATMENT OUTCOME; X-LINKED INHIBITOR OF APOPTOSIS PROTEIN; YOUNG ADULT;

EID: 84861523366     PISSN: 10802924     EISSN: None     Source Type: Journal    
DOI: 10.1532/LH96.11005     Document Type: Article

References (21)

1. Earnshaw WC, Martins LM, Kaufmann SH. Mammalian caspases: structure, activation, substrates, and functions during apoptosis. Annu Rev Biochern. (1999);68:383-424. (Pubitemid 29449198)
2. Schimmer AD, Dalili S, Batey BA, Riedl SJ. Targeting XIAP for the treatment of malignancy. Cell Death Differ. 2006;13:179-188. (Pubitemid 43102202)
3. Johnson ME, Howerth EW. Survivin, a bifunctional inhibitor of apoptosis protein. Vet Pathol. (2004);41:599-607. (Pubitemid 39573750)
4. Paydas S, Tanriverdi K, Yavuz S, Dise U, Sahin B, Burgut R. Survivin and aven: two distinct antiapoptotic signals in acute leukemias. Ann Oncol. 2003;14:1045-1050. (Pubitemid 36950168)
5. Cai Z, Bao HY, Lin MF. Correlation between survivin mRNA expression and homoharringtonine induced apoptosis of malignant hematopoietic cells. Chin Med J. 2005;118:548-554. (Pubitemid 40515014)
6. Chesin BD, Cassileth PA, Head DR, et al. Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia. J Clin Oncol. 1990;8:813-819. (Pubitemid 20148273)
7. Testa U, Riccioni R. Deregulation of apoptosis in acute myeloid leukemia. Haematologica. 2007;92:81-94. (Pubitemid 46237556)
8. Shinozawa I, Inokuchi K, Wakabayashi I, Dan K. Disturbed expression of the anti-apoptosis gene, survivin and EPR-1 in hematological malaignancies. Leuk Res. 2000;24:965-970.
9. Lin FR, Wang Y, Wang RQ, et al. Expression of survivin, Fas, bcl-2 and bax in bone marrow cells from acute myeloid leukemia patients and its clinical significance [in Chinese]. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2003;11:259-262.
10. Zhu FB, Wang SY, Zhang YW. Expression of antigen CD 40 and survivin gene and their clinical implications in acute myeloid leukemia [in Chinese]. Zhonghua Nei Ke Za Zhi. 2004;43:769-772.
11. Wang Y, Xu S, Lin FR, Guo XN, Ren JH. Expressions of cyclin E2 and survivin in acute myeloid leukemia and their correlation. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2006;14:337-342.
12. Tamm I, Richter S, Oltersdorf D, et al. High expression levels of x-linked inhibitor of apoptosis protein and survivin correlate with poor overall survival in childhood de novo acute myeloid leukemia. Clin Cancer Res. 2004;10:3737-3744. (Pubitemid 38697607)
13. Yamamoto K, Abe S, Nakagawa Y, et al. Expression of IAP family proteins in myelodysplastic syndromes transforming to overt leukemia. Leuk Res. 2004;28:1203-1211. (Pubitemid 39243246)
14. Chen GH, Lin FR, Ren JH, et al. Expression and significance of X-linked inhibitor of apoptosis protein and its antagonized proteins in acute leukemia [in Chinese]. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2006;14:639-643.
15. Altieri DC. The molecular basis and potential role of survivin in cancer diagnosis and therapy. Trends Mol Med. 2001;7:542-547. (Pubitemid 33127139)
16. Lin FR, Wang Y, Wang RQ, et al. Expression of survivin, Fas, bcl-2 and bax in bone marrow cells from acute myeloid leukemia patients and its clinical significance [in Chinese]. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2003;11:259-262.
17. Oto OA, Paydas S, Tanriverdi K, Seydaoglu G, Yavuz S, Disel U. Survivin and EPR-1 expression in acute leukemias: prognostic significance and review of the literature. Leuk Res. 2007;31:1495-1501. (Pubitemid 47632782)
18. Wagner M, Schmelz K, Wuchter C, Ludwig WD, Dörken B, Tamm I. In vivo expression of survivin and its splice variant survivin-2 B: impact on clinical outcome in acute myeloid leukemia. Int J Cancer. 2006;119:1291-1297. (Pubitemid 44258802)
19. Adida C, Recher C, Raffoux E, et al. Expression and prognostic significance of survivin in de novo acute myeloid leukaemia. Br J Haematol. 2000;111:196-203.
20. Tamm I, Kornblau SM, Segall H, et al. Expression and prognostic significance of IAP-family genes in human cancers and myeloid leukemias. Clin Cancer Res. 2000;6:1796-1803. (Pubitemid 30305074)
21. Carter BZ, Kornblau SM, Tsao T, et al. Caspase-independent cell death in AML: caspase inhibition in vitro with pan-caspase inhibitors or in vivo by XIAP or Survivin does not affect cell survival or prognosis. Blood. 2003;102:4179-4186. (Pubitemid 37487005)